MedPath

Efficacy of pramipexole treatment and methylphenidate for attention deficit hyperactivity disorder

Phase 2
Recruiting
Conditions
attention deficit hyperactivity disorder.
Disturbance of activity and attention
Registration Number
IRCT20100520003979N7
Lead Sponsor
Ahvaz University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
10
Inclusion Criteria

Age of children aged 6 to 12 years
Having diagnostic criteria based on IV-IRDSM and Conners test

Exclusion Criteria

The presence of other medical conditions (heart problem, kidney failure, epilepsy, etc.)
The presence of other serious psychiatric disorders such as mood disorders, penetrating disorders, and
The presence of symptoms of mental disability
a history of seizure

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Attention Deficit Hyperactivity Disorder. Timepoint: Befor intervention- the end of second, fourth and sixth,eighth, tenth,twelfth weeks of the study. Method of measurement: The Conner's parent rating scale.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath